Fareon Open Label Device Clinical Trial
- NCT ID
- NCT07600320
- Registry status
- Not yet recruiting
- Study type
- Not specified in the registry data
- Phase
- Not applicable
- Sponsor
- Icahn School of Medicine at Mount Sinai
Overview
ClinicalTrials.gov lists this study as Not yet recruiting.
Enrollment: 30 participants (Estimated).
What is being studied
No interventions are listed in the registry data.
Who may be eligible
- Ages
- Not specified in the registry data
- Sex
- Not specified in the registry data
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
IncInclusion Criteria:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
* Any sex/gender
* 16 years of age or older
* English Speaking
* Experiencing symptoms of at least self-reported mild cognitive impairment associated with a confirmed diagnosis of a condition such as Long COVID, Traumatic Brain Injury, other Acquired Brain Injuries, and other neurodegenerative diagnoses including but not limited to Alzheimer's disease
* Individuals of childbearing age agreeing to use a highly effective form of birth control for the duration of their participation
* Willing and able to sign informed consent or have a parent or LAR able to sign informed consent form
* Willing and able to attend all study visits virtually or in person
Exclusion Criteria:
Individual who meets any of the following criteria will be excluded from participation in this study:
* Enrollment in another interventional clinical trial in the last 90 days or during the study period
* Change in anti-depressant or other psychoactive medication or dose in the last 90 days
* Cranially implanted devices or metal
* Pacemaker
* History of seizure disorder
* Pregnant or plan to become pregnant during the study as indicated by proof of a positive pregnancy test
* Inability to achieve appropriate positioning of the study device on the head
* Any medical, psychiatric, or neurological condition, or concurrent treatment, that in the opinion of the Principal Investigator would interfere with study participation, interpretation of results, or pose additional risk to the participant.
Study locations
1 study location is listed.
Site recruitment status is not specified in the registry data for these locations.
Countries: United States
- New York, United States: 1
Sample of listed locations
- The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE) — New York, New York, 10029, United States — Site recruitment status not specified in the registry data
Study details
- Start date
- May 1, 2026
- Primary completion date
- April 30, 2027
- First posted
- May 20, 2026
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07600320
- Registry last updated
- May 20, 2026
- QualifiedStudies registry data refreshed
- September 21, 2026
View NCT07600320 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Chronic Fatigue Syndrome (CFS) studies | Clinical trial FAQ